|
Q4 FY2018
As of Mar 31, 2018
|
Q3 FY2018
As of Dec 31, 2017
|
Q2 FY2018
As of Sep 30, 2017
|
Q1 FY2018
As of Jun 30, 2017
|
Q4 FY2017
As of Mar 31, 2017
|
Q3 FY2017
As of Dec 31, 2016
|
Q2 FY2017
As of Sep 30, 2016
|
Q1 FY2017
As of Jun 30, 2016
|
Q4 FY2016
As of Mar 31, 2016
|
Q3 FY2016
As of Dec 31, 2015
|
Q2 FY2016
As of Sep 30, 2015
|
Q1 FY2016
As of Jun 30, 2015
|
Q4 FY2015
As of Mar 31, 2015
|
Q3 FY2015
As of Dec 31, 2014
|
Q2 FY2015
As of Sep 30, 2014
|
Q1 FY2015
As of Jun 30, 2014
|
Q4 FY2014
As of Mar 31, 2014
|
Q3 FY2014
As of Dec 31, 2013
|
Q2 FY2014
As of Sep 30, 2013
|
Q1 FY2014
As of Jun 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Deferred revenue and warranty liabilities | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Short-term indebtedness | ||||||||||||||||||||
| Bank indebtedness | ||||||||||||||||||||
| Accrued payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Deferred revenue and current warranty liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue and non-current warranty liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Preferred Stock, par value $0.001 per share; authorized 5,000; shares issued none | ||||||||||||||||||||
| Common Stock, par value $0.001 per share; authorized 15,000; shares issued 11,086 and 10,970, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholder’s equity | ||||||||||||||||||||
| Total liabilities and stockholder’s equity |
Loading...
